SCHEMBL24928006

SCHEMBL24928006

CC(C)(C)OC(=O)NCC1(c2cccnn2)NC(=O)NC1=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADAMTS7 Q9UKP4 8/20 0.36
CYP3A4 P08684 1/20 0.36
ADAMTS5 Q9UNA0 4/20 0.35
ADAMTS4 O75173 3/20 0.35
MMP2 P08253 3/20 0.35
MMP3 P08254 3/20 0.35
MMP13 P45452 3/20 0.35
MMP14 P50281 3/20 0.35
MAPK10 P53779 1/20 0.34
NAMPT P43490 1/20 0.34
ADAM17 P78536 3/20 0.34
MMP1 P03956 2/20 0.34
MMP7 P09237 2/20 0.34
MMP9 P14780 2/20 0.34
BCHE P06276 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PARP1 P09874 1/20 0.34
AKT1 P31749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29979092 1.00 ADAMTS7 (0.36) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2
SCHEMBL23354123 0.86 ADAMTS5 (0.46) ADAMTS7ADAMTS5ADAMTS4MMP2MMP13
SCHEMBL29873806 0.86 ADAMTS5 (0.46) ADAMTS7ADAMTS5ADAMTS4MMP2MMP13
SCHEMBL23354406 0.83 ADAMTS5 (0.39) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2
SCHEMBL29874400 0.80 CYP3A4 (0.52) CYP3A4ADAMTS5ADAMTS4MMP2MMP13
SCHEMBL24938581 0.80 CYP3A4 (0.52) CYP3A4ADAMTS5ADAMTS4MMP2MMP13
SCHEMBL29873860 0.80 MMP13 (0.43) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2
SCHEMBL23367190 0.80 MMP13 (0.43) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2
SCHEMBL24927817 0.79 ADAM17 (0.41) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2
SCHEMBL29978673 0.79 ADAM17 (0.41) ADAMTS7CYP3A4ADAMTS5ADAMTS4MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ADAMTS7 1/4885CYP3A4 3418/4885ADAMTS5 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.